Who Is Buying Outpatient Mental Health Practices?
- Feb 14, 2025
- 4 min read
Updated: 2 hours ago
How Strategic Buyers, Private Equity, and Growth Capital Are Reshaping the Industry during 2026
Mergium Advisors' survey of U.S. outpatient mental health M&A transactions identified 36 announced transactions during the first half of 2026, up from 26 transactions during the second half of 2025, indicating that acquisition activity remained resilient despite continued macroeconomic uncertainty and elevated financing costs.
Buyer composition shifted noticeably during the period. Strategic buyers accounted for 16 announced transactions in H1 2026, compared with 9 during H2 2025, making them the most active buyer group. Private equity-backed platforms completed 10 acquisitions, while growth capital-backed companies announced 6 transactions. By comparison, only 2 new private equity platform investments (buyouts) were identified during H1 2026, versus 5 during H2 2025.
The increase in strategic acquisitions should not necessarily be interpreted as a long-term structural shift away from private equity. Transaction volumes over individual six-month periods can fluctuate materially. Moreover, the sector continues to include a large number of private equity-backed platforms, as well as growth capital-backed companies, that remain active consolidators. As a result, strategic and sponsor-backed activity will likely continue to alternate in prominence depending on financing markets, platform maturity, and the availability of attractive acquisition targets.
Growth capital-backed companies are expected to remain another important driver of consolidation. Unlike private equity-backed platforms, these companies typically finance expansion through repeated private equity placements involving venture capital firms, growth equity investors, family offices, and institutional investors, rather than through traditional buyout funds. Since January 2025, they have averaged approximately six acquisitions per semester. Mental health continues to attract significant growth capital investment—particularly among technology-enabled providers with strong virtual care capabilities—creating an increasingly active class of serial acquirers.
Services Most Frequently Included in Transactions
The composition of acquired practices has remained relatively consistent over the last eighteen months.
Practices providing outpatient psychotherapy (talk therapy/counseling) represented the largest category of announced transactions, followed by psychiatry and medication management. Together, these services were present in the majority of announced transactions during the period.  They generate recurring patient relationships, diversified referral sources, and opportunities to expand into higher-acuity services.
Specialty service lines have also become increasingly visible. Announced transactions involving Transcranial Magnetic Stimulation (TMS) and ketamine treatment increased during H1 2026, reflecting growing investor interest in interventional psychiatry. These services generally offer higher reimbursement potential, meaningful clinical differentiation, and attractive opportunities for physician-led specialty platforms.
Intensive Outpatient Programs (IOPs) also continued to appear regularly in acquisitions, highlighting buyers' interest in providers capable of delivering multiple levels of outpatient behavioral health care.
Strategic Transactions During 2026 That Help Define the Market
Beacon Behavioral Partners Continues Building an Interventional Psychiatry Platform
Beacon Behavioral Partners continued its acquisition strategy by adding Carolina Psychiatry, Novus Neurology, and SunCoast Psychiatry during H1 2026.
Rather than pursuing broad-based outpatient psychiatry consolidation, Beacon—backed by Latticework Capital—appears to be assembling a differentiated physician-led platform centered on interventional psychiatry. The strategy combines physician-led regional practices offering advanced treatment modalities such as TMS while leveraging centralized management infrastructure. This approach creates opportunities for operational scale while preserving local clinical leadership.
BrainsWay's Minority Investments Represent a Different Form of Consolidation
BrainsWay completed minority investments in three outpatient TMS providers during H1 2026.
These announced transactions differ from traditional private equity investments. Rather than acquiring control of providers, BrainsWay is using minority equity investments as a strategic channel-development initiative designed to accelerate adoption of its Deep TMS technology while establishing long-term relationships with high-growth behavioral health providers.
From an M&A perspective, BrainsWay is effectively creating a network of affiliated treatment providers without becoming a healthcare operator itself. This model may represent an emerging alternative to traditional acquisition strategies for healthcare technology companies seeking to expand market penetration. The strategy aligns incentives between the equipment manufacturer and providers while expanding the installed base of its technology.
Universal Health Services' Acquisition of Talkspace
Universal Health Services' announced acquisition of Talkspace may prove to be one of the most strategically important behavioral health transactions of the year.
Historically, behavioral health consolidation has focused on acquiring physical treatment capacity—including hospitals, residential treatment centers, outpatient clinics, partial hospitalization programs (PHPs), and intensive outpatient programs (IOPs). The proposed acquisition of Talkspace reflects a different strategic objective: acquiring digital patient access, virtual care capabilities, and longitudinal patient engagement.
Rather than simply adding a telehealth business, UHS appears to be positioning itself to build a more integrated behavioral health platform that spans multiple levels of care—from digital therapy to higher-acuity treatment settings. If the integration achieves its intended objectives, the combined platform could strengthen patient retention, improve referrals across multiple levels of care, and enhance the economics of value-based behavioral health delivery.
Taken together, the first half of 2026 demonstrates that outpatient mental health remains one of the most active segments of behavioral healthcare M&A. While buyer composition continues to evolve, strategic acquirers, private equity-backed platforms, and growth capital-backed companies are all actively deploying capital through different investment strategies. At the same time, increasing interest in interventional psychiatry, virtual care, and integrated outpatient delivery models suggests that future consolidation will be driven not only by geographic expansion, but also by service differentiation and technology-enabled care delivery.
Additional resources:
If you need assistance selling or valuing your mental health company, contact us.
If you need to read more about selling a business, read more
If interested in reading more articles and insights by Mergium, click here
If interested in knowing about our experience in selling / acquiring healthcare services companies, click here